Bexotegrast, Placebo matching PLN-74809
PLN-74809-IPF-206
Phase 3 small_molecule active
Quick answer
Bexotegrast, Placebo matching PLN-74809 for Idiopathic pulmonary fibrosis (IPF) is a Phase 3 program (small_molecule) at PLIANT THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PLIANT THERAPEUTICS, INC.
- Indication
- Idiopathic pulmonary fibrosis (IPF)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active